Used in pharmaceutical research as a potent and selective inhibitor of certain kinases involved in inflammatory and oncogenic signaling pathways. Shows promise in the development of targeted therapies for cancer, particularly in models of leukemia and solid tumors. Its structure allows for high binding affinity to ATP-binding sites of specific protein kinases, making it a valuable scaffold in medicinal chemistry for optimizing drug candidates. Also investigated for use in positron emission tomography (PET) tracer development due to its favorable pharmacokinetic profile and ability to cross cell membranes efficiently.